120 related articles for article (PubMed ID: 7238825)
1. Beneficial action of naloxone in splanchnic artery occlusion shock.
Curtis MT; Lefer AM
Experientia; 1981 Apr; 37(4):403-4. PubMed ID: 7238825
[No Abstract] [Full Text] [Related]
2. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of splanchnic artery occlusion (SAO) shock by cysteine.
Galvin MJ; Lefer AM
Adv Shock Res; 1978; 1():261-70. PubMed ID: 262085
[No Abstract] [Full Text] [Related]
4. Sulfatide reduces leucocyte accumulation and reverts vascular failure in splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Squadrito G; Campo GM; Arlotta M; Quartarone C; Minutoli L; Ferlito M; Saitta A; Caputi AP
Eur J Pharmacol; 1998 Nov; 361(1):101-8. PubMed ID: 9851547
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock.
Lefer AM
Prog Clin Biol Res; 1983; 111():111-23. PubMed ID: 6191336
[No Abstract] [Full Text] [Related]
6. Use of a novel peptide leukotriene receptor antagonist, Ly-163443, in splanchnic artery occlusion shock.
Bitterman H; Lefer AM
Prostaglandins Leukot Essent Fatty Acids; 1988 May; 32(2):63-70. PubMed ID: 3406041
[TBL] [Abstract][Full Text] [Related]
7. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
Zingarelli B; Squadrito F; Ioculano M; Altavilla D; Bussolino F; Campo GM; Caputi AP
Eur J Pharmacol; 1992 Nov; 222(1):13-9. PubMed ID: 1468489
[TBL] [Abstract][Full Text] [Related]
8. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
Aoki N; Johnson G; Lefer AM
Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894
[TBL] [Abstract][Full Text] [Related]
10. Protective actions of naloxone in hemorrhagic shock.
Curtis MT; Lefer AM
Am J Physiol; 1980 Sep; 239(3):H416-21. PubMed ID: 7435587
[TBL] [Abstract][Full Text] [Related]
11. Circulating dopamine levels and a protective action of naloxone in canine splanchnic arterial occlusion shock.
Eddy LJ; Joiner DW; Glenn TM
Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):113-25. PubMed ID: 6701397
[TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
Squadrito F; Sturniolo R; Altavilla D; Santoro G; Campo GM; Arena A; Caputi AP
Eur J Pharmacol; 1991 Jan; 192(1):47-53. PubMed ID: 2040364
[TBL] [Abstract][Full Text] [Related]
13. Effects of fructose 1,6-diphosphate on splanchnic artery occlusion shock in the rat.
Squadrito F; Sturniolo R; Altavilla D; Campo GM; Trimarchi GR; Scuri R; Caputi AP
Resuscitation; 1989 Dec; 18(2-3):299-307. PubMed ID: 2555881
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of a specific leukotriene receptor antagonist in splanchnic artery occlusion shock.
Lento PH; Saukkonen K; Aoki N; Lefer AM; Slivjak MJ; Smith EF
Eur J Pharmacol; 1989 Jun; 165(2-3):241-9. PubMed ID: 2550251
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of the specific thromboxane receptor antagonist (+)-S145Na in splanchnic artery occlusion shock in rats.
Furlan LE; Johnson G; Siegfried M; Lefer AM
J Pharmacol Exp Ther; 1990 May; 253(2):525-9. PubMed ID: 2140129
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of thromboxane receptor blockade in splanchnic artery occlusion shock.
Aoki N; Lefer AM
Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):413-8. PubMed ID: 3419244
[TBL] [Abstract][Full Text] [Related]
17. Passive immunization with antibodies against tumor necrosis factor (TNF-alpha) protects from the lethality of splanchnic artery occlusion shock.
Squadrito F; Altavilla D; Ioculano M; Calapai G; Zingarelli B; Saitta A; Campo GM; Rizzo A; Caputi AP
Circ Shock; 1992 Jul; 37(3):236-44. PubMed ID: 1423915
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid in splanchnic artery occlusion shock.
Bridenbaugh GA; Flynn JT; Lefer AM
Am J Physiol; 1976 Jul; 231(1):112-9. PubMed ID: 961849
[TBL] [Abstract][Full Text] [Related]
19. The effects of naloxone on the peripheral sympathetics in cat endotoxin shock.
Koyama S; Santiesteban HL; Ammons WS; Manning JW
Circ Shock; 1983; 10(1):7-13. PubMed ID: 6339102
[TBL] [Abstract][Full Text] [Related]
20. Peripheral effects of opiate antagonists in shock.
Lefer AM; Curtis MT
Adv Shock Res; 1983; 10():83-6. PubMed ID: 6308976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
